Type 2 Diabetes

US Nursing Home Costs Due to Diabetes Vary Greatly by State

US Nursing Home Costs Due to Diabetes Vary Greatly by State

Per-person diabetes-attributable costs ranged from 374 in New Mexico to 1,610 in Washington, D.C.

Diabetes and Mortality: Comparing SGLT-2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors

Diabetes and Mortality: Comparing SGLT-2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors

By

For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists significantly reduce mortality rates compared with dipeptidyl peptidase 4 inhibitors.

Diabetes Prevalence by Type in the United States: CDC report

Diabetes Prevalence by Type in the United States: CDC report

By

The CDC conducted a study to estimate the prevalence of diagnosed diabetes among adults in 2016 by primary type.

Case Study in Diabetes: Fungal Infections

Case Study in Diabetes: Fungal Infections

A 68-year-old patient with type 2 diabetes presents to a urologist to evaluate funguria, and a CT scan showed right hydroureteronephrosis.

Inflammatory Bowel Disease Risk Associated with DPP-4 Inhibitor Use

Inflammatory Bowel Disease Risk Associated with DPP-4 Inhibitor Use

By

Patients with type 2 diabetes have a greater risk for developing inflammatory bowel disease when using dipeptidyl peptidase-4 inhibitors.

ACP supports higher HbA1c targets for pharmacotherapy in adults with T2D

ACP supports higher HbA1c targets for pharmacotherapy in adults with T2D

By

ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.

High fiber diet beneficial for gut bacteria development in type 2 diabetes

High fiber diet beneficial for gut bacteria development in type 2 diabetes

A high fiber diet promotes gut bacteria that helps blood glucose control in patients with type 2 diabetes.

New type 2 diabetes guideline recommends more moderate HbA1c target

New type 2 diabetes guideline recommends more moderate HbA1c target

By

The American College of Physicians has developed recommendation statements to guide clinicians in selecting targets for pharmacologic treatment of type 2 diabetes.

Metformin, statins not associated with ovarian cancer

Metformin, statins not associated with ovarian cancer

The incidence of ovarian cancer was not related to metformin or statin usage among women with type 2 diabetes.

Gestational diabetes increases T2D, hypertension, heart disease risk

Gestational diabetes increases T2D, hypertension, heart disease risk

By

Women with gestational diabetes have a greater risk of developing T2D and cardiovascular events than women who were not previously diagnosed with the disease.

Type 2 diabetes may be reversed with weight loss, physician care

Type 2 diabetes may be reversed with weight loss, physician care

With the help of a doctor and a weight loss plan, new research suggests type 2 diabetes can be reversed in less than a year.

FDA approves weekly diabetes drug that may also be beneficial for weight loss

FDA approves weekly diabetes drug that may also be beneficial for weight loss

By

The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Commercial weight loss program may help prevent diabetes in obese patients

Commercial weight loss program may help prevent diabetes in obese patients

Primary care referral to Weight Watchers meetings is associated with weight loss, HbA1c reduction.

Statins associated with increased risk of diabetes in high-risk individuals

Statins associated with increased risk of diabetes in high-risk individuals

By

Statins are associated with an increased risk for developing type 2 diabetes, especially for high-risk individuals.

Cognitive behavioral group therapy ineffective for weight maintenance in type 2 diabetes

Cognitive behavioral group therapy ineffective for weight maintenance in type 2 diabetes

CBGT did not prevent overweight and obese patients with type 2 diabetes from regaining weight lost during weight loss programs.

Antidepressant use linked to type 2 diabetes in young adults

Antidepressant use linked to type 2 diabetes in young adults

By

Type 2 diabetes risk is increased in young adults through antidepressant use, specifically the duration of use and the cumulative dose.

Diabetes risk greater in children, young adults on second-generation antipsychotics

Diabetes risk greater in children, young adults on second-generation antipsychotics

Type 2 diabetes is greater with second-generation antipsychotics than with non-second-generation antipsychotic psychotropic medications for patients aged 6 to 25 years.

Evidence finds link between antidepressant drug use and type 2 diabetes

Evidence finds link between antidepressant drug use and type 2 diabetes

By

After the inclusion of recent negative studies, a statistically significant association between AD use and diabetes was observed.

Shorter sleep duration linked to higher diabetes risk in children

Shorter sleep duration linked to higher diabetes risk in children

By

Sleep duration for 1 hour longer was associated with lower BMI, fat mass, insulin resistance, and fasting glucose but had no effect on HbA1c or cardiovascular risk.

Lifestyle intervention provides minimal benefit in improving glycemic control in type 2 diabetes

Lifestyle intervention provides minimal benefit in improving glycemic control in type 2 diabetes

By

Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.

Earlier menopause may increase risk of type 2 diabetes

Earlier menopause may increase risk of type 2 diabetes

Women who experienced early menopause were 2.4 times more likely to develop diabetes.

Moderate weight gain in early to middle adulthood linked to increased risk of chronic diseases

Moderate weight gain in early to middle adulthood linked to increased risk of chronic diseases

By

Adulthood weight gain is associated with an increased risk of major chronic diseases and mortality.

Type 2 diabetes patients benefit from depression screening

Type 2 diabetes patients benefit from depression screening

By

The annual screening could decrease negative health outcomes and may be a cost-effective way to reduce complications.

Degludec vs glargine in type 2 diabetes for cardiovascular events

Degludec vs glargine in type 2 diabetes for cardiovascular events

By

Degludec is noninferior to glargine regarding the incidence of major cardiovascular events among patients with type 2 diabetes.

Some antidiabetic agents may increase pneumonia risk in type 2 diabetes

Some antidiabetic agents may increase pneumonia risk in type 2 diabetes

By

Compared with current use of metformin + sulfonylurea, the use of thiazolidinediones + metformin was associated with an increased risk of community-acquired pneumonia.

Insulin pump therapy improves quality of life in adolescents with type 2 diabetes

Insulin pump therapy improves quality of life in adolescents with type 2 diabetes

By

Adolescents with type 2 diabetes decreased HbA1c levels after using insulin pump therapy for a 3-month period.

High BMI in late adolescence associated with increased risk of severe liver disease in men

High BMI in late adolescence associated with increased risk of severe liver disease in men

By

A high BMI is associated with an increased risk for severe liver disease, and the risk is higher in those who also have type 2 diabetes mellitus.

Insulin initiation in primary care improves HbA1c levels

Insulin initiation in primary care improves HbA1c levels

By

The Stepping Up model of care produced a clinically and significantly significant improvement in HbA1c among adults with type 2 diabetes managed in primary care.

Nearly half of all cardiometabolic deaths linked to poor diet

Nearly half of all cardiometabolic deaths linked to poor diet

By

Suboptimal intake of 10 specific dietary factors is associated with a substantial proportion of deaths due to heart disease, stroke, or type 2 diabetes.

Metformin, vildagliptin have differing effects on heart rate, blood pressure in diabetes

Metformin, vildagliptin have differing effects on heart rate, blood pressure in diabetes

Vildagliptin lowers blood pressure and elevates heart rate, while metformin increases heart rate with no effect on blood pressure.

Sign Up for Free e-newsletters